Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Colao

Showing results (341-350 of 391) with videos related to

Pageof 40
Sort By:
Journal of Endocrinological Investigation|May 14, 2008
Usefulness of [111In-DTPA0] octreotide scintigraphy in a family with von Hippel-Lindau diseaseM Pulcrano, L Camera, L Pagano, et al.
Journal of Endocrinological Investigation|May 28, 2002
Impairment of GH secretion in adults with primary empty sellaM Gasperi, G Aimaretti, E Cecconi, et al.
Journal of Endocrinological Investigation|March 9, 2010
Primary empty sella: Why and when to investigate hypothalamic-pituitary functionA Giustina, G Aimaretti, M Bondanelli, et al.
Journal of Endocrinological Investigation|July 19, 2011
Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: Implications for the in vivo visualization during somatostatin receptor scintigraphyD Ferone, R Pivonello, D J Kwekkeboom, et al.
European Journal of Endocrinology|April 23, 2008
Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaireS M Webb, X Badia, M J Barahona, et al.
Neuroendocrinology|April 23, 2004
Expression and function of somatostatin receptor subtype 1 in human growth hormone secreting pituitary tumors deriving from patients partially responsive or resistant to long-term treatment with somatostatin analogsC Matrone, R Pivonello, A Colao, et al.
Journal of Cellular and Molecular Medicine|September 3, 2011
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro studyA Faggiano, V Ramundo, A Dicitore, et al.
Journal of Biological Regulators and Homeostatic Agents|January 27, 2015
Increased risk of osteoporosis in postmenopausal women with type 2 diabetes mellitus: a three-year longitudinal study with phalangeal QUS measurementsC Neglia, N Agnello, A Argentiero, et al.
Journal of Endocrinological Investigation|November 20, 2019
Association between biochemical control and comorbidities in patients with acromegaly: an Italian longitudinal retrospective chart review studyA Colao, L F S Grasso, M Di Cera, et al.
Hormone Research in Paediatrics|January 10, 2014
Impaired bone metabolism in glycogen storage disease type 1 is associated with poor metabolic control in type 1a and with granulocyte colony-stimulating factor therapy in type 1bD Melis, R Pivonello, M Cozzolino, et al.
Pageof 40

Showing results (341-350 of 391) with videos related to

Sort By:
Pageof 40
Journal of Endocrinological Investigation|May 14, 2008
Usefulness of [111In-DTPA0] octreotide scintigraphy in a family with von Hippel-Lindau diseaseM Pulcrano, L Camera, L Pagano, et al.
Journal of Endocrinological Investigation|May 28, 2002
Impairment of GH secretion in adults with primary empty sellaM Gasperi, G Aimaretti, E Cecconi, et al.
Journal of Endocrinological Investigation|March 9, 2010
Primary empty sella: Why and when to investigate hypothalamic-pituitary functionA Giustina, G Aimaretti, M Bondanelli, et al.
Journal of Endocrinological Investigation|July 19, 2011
Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: Implications for the in vivo visualization during somatostatin receptor scintigraphyD Ferone, R Pivonello, D J Kwekkeboom, et al.
European Journal of Endocrinology|April 23, 2008
Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaireS M Webb, X Badia, M J Barahona, et al.
Neuroendocrinology|April 23, 2004
Expression and function of somatostatin receptor subtype 1 in human growth hormone secreting pituitary tumors deriving from patients partially responsive or resistant to long-term treatment with somatostatin analogsC Matrone, R Pivonello, A Colao, et al.
Journal of Cellular and Molecular Medicine|September 3, 2011
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro studyA Faggiano, V Ramundo, A Dicitore, et al.
Journal of Biological Regulators and Homeostatic Agents|January 27, 2015
Increased risk of osteoporosis in postmenopausal women with type 2 diabetes mellitus: a three-year longitudinal study with phalangeal QUS measurementsC Neglia, N Agnello, A Argentiero, et al.
Journal of Endocrinological Investigation|November 20, 2019
Association between biochemical control and comorbidities in patients with acromegaly: an Italian longitudinal retrospective chart review studyA Colao, L F S Grasso, M Di Cera, et al.
Hormone Research in Paediatrics|January 10, 2014
Impaired bone metabolism in glycogen storage disease type 1 is associated with poor metabolic control in type 1a and with granulocyte colony-stimulating factor therapy in type 1bD Melis, R Pivonello, M Cozzolino, et al.
Pageof 40